2023 Omaha Patient and Family Hybrid Conference
Here are the session recordings and the presentations for the 2023 Omaha Patient and Family Hybrid Conference.
Myelodysplastic Syndromes (MDS)
Updates from ASH22 on MDS and AML
Topic(s)
Myelodysplastic Syndromes (MDS)
Acute Myeloid Leukemia (AML)
In this webinar, Dr. Lourdes Mendez discusses research most relevant to patients reported over the past year on the biology and treatment on MDS and secondary AML. These studies were presented at the American Society of Hematology (ASH) 2022 meeting. Research findings are…
Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes
Original Publication Date
Article Source
External Web Content
ABSTRACT PURPOSE Myelodysplastic syndromes (MDS) are heterogeneous myeloid neoplasms in which a risk-adapted treatment strategy is needed. Recently, a new clinical-molecular prognostic model, the Molecular International Prognostic Scoring System (IPSS-M) was proposed to improve…
Damian Laber, MD
Institution
Moffit Cancer Center
Physician Status
accepting new patients
Primary Disease Area of Focus
Myelodysplastic Syndromes (MDS)
Paroxysmal Nocturnal Hemoglobinuria (PNH)
About
Dr. Laber is a hematologist/oncologist and senior member with Moffitt Medical Group in the Satellite and Community Oncology Department practicing at Tampa General Hospital and Moffitt international Plaza. The MMG faculty at TGH provides invaluable oncology services to the large patient population of this leading regional hospital. Dr. Laber earned his M.D. at the University of Buenos Aires, Argentina. He completed his residency in internal medicine at Cleveland Clinic Health System, and was designated Chief Resident during his term at Hillcrest and Southpointe Hospitals. Dr. Laber’s research
2022 Miami Patient and Family Hybrid Conference: Transplantation for Bone Marrow Failure
Topic(s)
Bone Marrow Transplant
Presenter(s)
Antonio Jimenez Jimenez, MD
Bone marrow transplantation is rigorous, so understanding the challenges from the process is essential. Learn from Dr. Antonio Jimenez Jimenez all about what patients can expect when this treatment is selected.
Antonio Jimenez Jimenez, MD
Institution
University of Miami Health System - Sylvester Comprehensive Cancer Center
Physician Status
accepting new patients
Primary Disease Area of Focus
Myelodysplastic Syndromes (MDS)
2022 Miami Patient and Family Hybrid Conference - Low-Risk MDS
Topic(s)
Myelodysplastic Syndromes (MDS)
Presenter(s)
Mikkael Sekeres, MD, MS
Mikkael Sekeres, MD, MS, explains Low-Risk MDS, or Myelodysplastic Syndromes, in this session. This presentation reveals answers to most questions that patients and families have.
2022 Miami Patient and Family Virtual Conference - Living with Bone Marrow Failure Disease
Topic(s)
Living Well with Bone Marrow Failure
Presenter(s)
Amber Thomassen, APRN-BC, AOCNP
The patient's life changes with diagnosis of any bone marrow failure disease. Learn how to adapt and thrive from Amber Thomassen, APRN-BC, AOCNP, in this session recording.
2022 Miami Patient and Family Hybrid Conference: High-Risk MDS and AML
Topic(s)
Acute Myeloid Leukemia (AML)
Myelodysplastic Syndromes (MDS)
Presenter(s)
Namrata Chandhok, MD
Learn about living with High-Risk MDS, Myelodysplastic Syndromes in this session. Learn about treatments and therapies for MDS and AML in this session with Dr. Namrata S. Chandok.